ATP-induced IL-1β secretion is selectively impaired in microglia as compared to hematopoietic macrophages

Saskia Maria Burm1, Ella Alwine Zuiderwijk-Sick1, Paola Massiel Weert1

  • 1Alternatives Unit, Biomedical Primate Research Centre, Lange Kleiweg 161, 2288 GJ Rijswijk, The Netherlands.

Glia
|September 20, 2016
PubMed

Insights

Extracellular ATP triggers inflammasome activation and IL-1β secretion. Microglia, unlike macrophages, show reduced IL-1β release due to distinct purinergic receptor usage, potentially protecting the central nervous system.

Area of Science:

  • Neuroimmunology
  • Innate Immunity
  • Cellular Signaling

Background:

  • Extracellular nucleotides, like ATP, signal danger via purinergic receptors (P2X, P2Y).
  • High extracellular ATP concentrations activate P2X7 receptors, leading to inflammasome activation and pro-inflammatory cytokine release (e.g., IL-1β).
  • Microglia are key innate immune cells in the central nervous system (CNS) and their inflammasome responses are critical in neurodegeneration.

Purpose of the Study:

  • To compare ATP-induced IL-1β secretion between primary rhesus macaque microglia and bone marrow-derived macrophages (BMDM).
  • To investigate the role of purinergic receptors in mediating IL-1β secretion in these cell types.
  • To understand cell type-specific differences in innate immune responses within the CNS.

Main Methods:

  • Primary rhesus macaque microglia and BMDM were cultured.
  • ATP-induced IL-1β secretion was measured.
  • Full expression profiles of P2 receptors were assessed.
  • Purinergic receptor agonists and antagonists were used to determine signaling pathways.

Main Results:

  • Microglia secreted significantly lower levels of IL-1β in response to ATP compared to BMDM.
  • Differences in IL-1β secretion were attributed to variations in purinergic receptor expression and usage, not ATP metabolism.
  • BMDM IL-1β secretion was P2X7-dependent, while microglia involved multiple receptors, including P2X7 and P2X4.

Conclusions:

  • Microglia exhibit distinct purinergic receptor-mediated regulation of IL-1β secretion compared to BMDM.
  • These cell-specific immune responses may represent adaptations to the unique and vulnerable CNS environment.
  • Understanding these differences is crucial for developing targeted therapies for neurodegenerative diseases.

Related Concept Videos